Logo Prima Biomed

Welcome to the Newsroom

06 July 2017

Disclosure Under Listing Rules 3.10.5A and 7.1A.4(b)



Sydney, Australia - Prima BioMed Ltd (ASX: PRR; NASDAQ: PBMD) (Prima or the Company) On 30 June 2017, the Company announced that it had entered into a securities purchase agreement with certain accredited investors to purchase 2,631,268 American Depositary Shares (ADS). Each Nasdaq-listed ADS represents 100 ordinary shares in Prima BioMed. The company will also issue warrants to purchase up to 1,973,451 of its ADS.